Mounjaro

€234,99

Treatment of obesity and type 2 diabetes.

Control blood sugar levels and reduce appetite.

Kas įskaičiuota į kainą?

Įeina medicininė konsultacija ir receptas, jei tai klinikiniais atvejais tinkama, o jūsų gydymas išduodamas ir pristatomas tiesiai į namus. Teikiami nuolatiniai klinikiniai stebėjimai ir patikros, siekiant palaikyti gydymą ir stebėti pažangą.

Garantijos

Tą pačią dieną išsiunčiame patvirtintus užsakymus
Diskretiškas, konfidencialus pristatymas
Ekspertų klinikinės konsultacijos
Atsakingas klientų aptarnavimas

Reikalingas galiojantis asmens tapatybės dokumentas

Prieš išrašant receptą ir išduodant šį vaistą, būtina patvirtinti tapatybę. Užsakymo pateikimo metu būsite paprašyti pateikti galiojantį asmens dokumentą. Priimami asmens dokumentai yra nacionalinis asmens tapatybės kortelė, pasas arba vairuotojo pažymėjimas.

Stiprumas: 2.5mg

2.5mg
5mg
7.5mg
10mg
12.5mg
15mg

Produkto variantai

Pradėkite savo konsultaciją

Our customers say Excellent Rated 4.3 Trustpilot Trustpilot

Greita santrauka

Vaistų rūšis

Dual GIP and GLP-1 receptor agonist.

Veikia pagal

Control blood sugar levels and reduce appetite.

Veiklioji medžiaga

Tirzepatide

Veiksminga per

Within a few weeks.

Generinis?

No

Šalutinis poveikis

Nausea, vomiting, diarrhea, decreased hunger, stomach pain, and constipation.

How it works

Clinician-led care, designed to be simple from start to finish.

1

Step 1

Check eligibility

Answer a short 2-minute questionnaire so we can understand your goals and medical history.

2

Step 2

Doctor approval

If eligible, one of our doctors issues your free prescription within 24 hours.

3

Step 3

Fast delivery, ongoing support

Next-day delivery across the EU, with support at every step of your treatment.

Vaistų informacija

Aprašymas

Mounjaro® (Tirzepatidas) yra pažangus svorio kontrolės gydymas, imituojantis du natūralius jūsų kūno hormonus: GLP-1 ir GIP. Veikdamas tuo pačiu metu su šiomis dviem atskiromis signalų sistemomis, jis padeda efektyviau reguliuoti apetitą nei gydymo būdai, naudojantys tik vieną. Šis unikalus dvigubas poveikis padeda ilgiau jaustis sotiems ir slopina maisto troškimus, todėl lengviau laikytis sveikesnės rutinos.

Sukurta paprastumui, Mounjaro pateikiamas patogioje daugkartinio naudojimo pakuotėje. Kiekvienoje pakuotėje yra 4 savaitinės dozės (pilnas mėnesio tiekimas) ir adatos, todėl jūsų gydymo planas yra lengvai valdomas.

Naudojimo instrukcija

Once a week one injection.

Ingredientai

Active Ingredient Tirzepatide Each pre-filled pen contains 0.5 ml of solution. The medication is available in the following strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. Other Ingredients (Excipients) Disodium hydrogen phosphate heptahydrate (E339) Sodium chloride Sodium hydroxide (for pH adjustment) Concentrated hydrochloric acid (for pH adjustment) Water for injections

Šalutinis poveikis

Gastrointestinal problems (nausea, vomiting, diarrhoea, constipation), a potential risk of hypoglycaemia (especially when used with other diabetes medications), injection site reactions, and other effects depending on the individual’s health status and other medicines taken.

Įspėjimai

When using Mounjaro (tirzepatide), it is important to take certain precautions. Be alert to severe abdominal pain, which may indicate pancreatitis. Monitor blood sugar levels closely, as there is a risk of hypoglycaemia when Mounjaro is used together with other diabetes medications. Report any changes in urination, which could signal kidney problems, and seek medical advice promptly if you experience persistent digestive symptoms such as vomiting or diarrhoea.

It is also essential to inform your doctor of any personal or family history of thyroid cancer, as studies in rodents have linked medicines similar to Mounjaro to thyroid-related issues. Watch for signs of allergic reactions, and if you are pregnant or breastfeeding, consult your healthcare professional about potential risks before using this medication.

Jūsų istorijos, mūsų pasididžiavimas

Dažniausiai užduodami klausimai

What is the difference between Mounjaro and Wegovy?How quickly does Mounjaro start to work?

Both medications are effective injectable treatments for weight management, but they work in slightly different ways.

Wegovy (Semaglutide) mimics one natural hormone called GLP-1. It primarily focuses on regulating appetite and slowing down digestion to help you feel full.

Mounjaro (Tirzepatide) is a newer treatment that mimics two hormones: GLP-1 and GIP. By targeting both signals at the same time, Mounjaro acts on improved appetite control and metabolic regulation. Clinical studies suggest that this "dual action" may lead to greater weight loss results for some patients compared to treatments that target only one hormone.

How quickly does Mounjaro start to work?

The onset of Mounjaro's effects can vary, but patients may begin to see improvements in their blood sugar levels and weight within a few weeks of starting treatment. Continuous use in conjunction with diet and exercise enhances its efficacy.

How is Mounjaro administered?

Mounjaro is administered as a subcutaneous injection once a week. It can be injected into the abdomen, thigh, or upper arm, with the site of injection rotated each week to minimise the risk of skin irritation.

How should Mounjaro be stored?

Mounjaro should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Keep the pen in its original packaging to protect from light. Once in use, it may be kept at room temperature for 30 days.

Do I need a prescription for Mounjaro?

Yes, Mounjaro is a prescription medication. You will need to consult a healthcare provider to determine if it's appropriate for your condition and to receive a prescription. Using our online consultation service will enable you to answer a short questionnaire that would be used by one of our clinical prescribers to determine your eligibility for the treatment and approve or decline and refund your order.